{"pmid": "12056703", "sentences": {"sent_1": {"Section": "", "text": "PATIENTS AND METHODS : Twelve patients with chemorefractory SCLC participated in this pilot trial of paclitaxel combined with G3139 .", "entities": {"entity_1": {"text": "chemorefractory SCLC", "class": "Participant", "negation": 0, "UMLS": "C0149925:sclc,", "index": 1, "start": 7}, "entity_2": {"text": "paclitaxel", "class": "Intervention", "negation": 0, "UMLS": "C0144576:paclitaxel,", "index": 2, "start": 15}}, "relations": {}}, "sent_2": {"Section": "", "text": "G3139 was given by continuous i.v. infusion over 7 days at a fixed dose of 3 mg / kg / day .", "entities": {"attribute_1": {"text": "3 mg / kg / day", "class": "measure", "negation": 0, "UMLS": "C1561538:day,", "index": 1, "start": 15}}, "relations": {}}}}